Chemotherapeutic 6-thio-2'-deoxyguanosine selectively targets and inhibits telomerase by inducing a non-productive telomere-bound telomerase complex.

Saved in:
Bibliographic Details
Title: Chemotherapeutic 6-thio-2'-deoxyguanosine selectively targets and inhibits telomerase by inducing a non-productive telomere-bound telomerase complex.
Authors: Sanford SL; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Badstübner M; Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, CA, USA., Gerber M; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Mannherz W; Division of Hematology/Oncology and Stem Cell Program, Boston Children's Hospital, Boston, MA, USA.; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Biological and Biomedical Sciences Program, Harvard/MIT MD-PhD Program, Harvard Stem Cell Institute, Harvard Initiative for RNA Medicine, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Lampl N; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Biological and Biomedical Sciences Program, Harvard/MIT MD-PhD Program, Harvard Stem Cell Institute, Harvard Initiative for RNA Medicine, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Dannenberg R; Department of Chemistry, The Pennsylvania State University, University Park, PA 16802, USA., Hinchie A; Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, PA, USA.; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Schaich MA; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Myong S; Program in Cell, Molecular, Developmental Biology and Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA.; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Hedglin M; Department of Chemistry, The Pennsylvania State University, University Park, PA 16802, USA., Agarwal S; Division of Hematology/Oncology and Stem Cell Program, Boston Children's Hospital, Boston, MA, USA.; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Biological and Biomedical Sciences Program, Harvard/MIT MD-PhD Program, Harvard Stem Cell Institute, Harvard Initiative for RNA Medicine, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Alder JK; Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, PA, USA.; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Stone MD; Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, CA, USA., Opresko PL; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Jun 27. Date of Electronic Publication: 2025 Jun 27.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2025.02.05.636339